Clinical Study

Impact of Substance Use Disorder on Presentation and Short-Term Course of Schizophrenia

Table 4

PANSS, Calgary scale for depression, HARS, and BPRS scores at 6 weeks in schizophrenia patients with substance use disorder (Group 1) and without substance use disorder (Group 2).

Variables Group 1 ( ) Mean ± s.d.Group 2 ( ) Mean ± s.d. Sig CI Lower boundCI Upper bound

PANSS Positive scale −0.1300.897−2.1431.879
Negative scale 0.8780.382−1.4133.672
Negative scale 
Difficulty in abstraction
2.1000.0380.031.146
General scale −0.6260.532−3.1981.659

HARSTotal score 1.2690.207−0.7733.548

BPRSTotal score 0.1760.860−2.8353.390
Mannerism/posturing −1.4410.152−0.27−0.42

Calgary scale for depressionDepression 1.7070.090−0.030.468
Self-depreciation 1.9870.0490.0010.400
Early waking 2.2350.0270.020.383
Total score 1.8270.070−0.1032.625

CI: confidence interval; “ ”: statistic; degree of freedom = 141.